financetom
Business
financetom
/
Business
/
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
Oct 17, 2025 1:21 PM

Oct 17 (Reuters) -

* U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN

SYNOPSYS

AND ANSYS DEAL

* U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN

SYNOPSYS

AND ANSYS DEAL

Source text: https://www.ftc.gov/news-events/news/press-releases/2025/10/ftc-approves-final-divestiture-order-synopsys-ansys-deal

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Commerzbank on Overnight News
Commerzbank on Overnight News
Jun 23, 2025
06:14 AM EDT, 06/23/2025 (MT Newswires) -- Commerzbank in its European Sunrise note of Monday highlighted: Markets: United States Treasuries dropped, then stabilized, with 10-year yield up 2bps. The Bund future is also lower. E-minis and Asian stocks are modestly weaker. US dollar gains, EUR hovers around $1.1485. Brent briefly spiked above $81/barrel, then fell back to $78. Gold trades...
Novo Nordisk Says Mim8 Well-Tolerated After Treatment Switch in Phase 3b Study for Bleeding Disorder
Novo Nordisk Says Mim8 Well-Tolerated After Treatment Switch in Phase 3b Study for Bleeding Disorder
Jun 23, 2025
06:09 AM EDT, 06/23/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Sunday its phase 3b study found switching to Mim8 from emicizumab without a break was well-tolerated in adults and adolescents with haemophilia A, a genetic bleeding disorder. No safety concerns were identified. There were also no thromboembolic events, hypersensitivty reactions or treatment-related adverse events leading to discontinuation,...
Exclusive-UAW investment blunder cost the union an estimated $80 million, documents show
Exclusive-UAW investment blunder cost the union an estimated $80 million, documents show
Jun 23, 2025
DETROIT (Reuters) -The United Auto Workers' leadership is mired in turmoil over allegations of an investment blunder that officials say cost the union about $80 million in potential gains from its financial portfolio, according to seven UAW officials and employees and union documents reviewed by Reuters. The investment funds were liquidated to pay striking workers in 2023 but weren't reinvested...
Copyright 2023-2026 - www.financetom.com All Rights Reserved